What is the fee on Kalshi for this market?

At the current typical price of 56¢, about 2¢ per contract (7% × price × (1 − price), rounded up, on orders that take liquidity). On a $50 trade that is about $1.54.

What win rate do I need to break even?

About 58% if you hold to settlement, against a market price of 56%. The gap is the fee.

Markets › Kalshi › Science and Technology

Beam Therapeutics Drug Application on Kalshi

If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Jan 1, 2027, then the market resolves to Yes.

Settles on: Food and Drug Administration.

Market says (typical open contract)

56%

Median YES price across 3 open contracts, 10 Nov 2026 09:57 UTC.

Real-world odds

—

No independent base rate yet. Until we connect one (sportsbook consensus, forecasts, the score), the market's own price is the best public forecast, and the fee sits on top of it.

Luck needed meter

88% 😈

Mostly luck. The market itself expects the favorite to lose this often; the fee is the only certainty.

The cover charge

Fee and break-even by purchase price
If you buy at	Fee per contract	On $50	Win rate to break even
30¢	1.5¢	$2.45	31.5%
50¢	1.8¢	$1.75	51.7%
56¢ (now)	1.7¢	$1.54	57.7%
70¢	1.5¢	$1.05	71.5%
90¢	0.6¢	$0.35	90.6%

Resting orders pay no fee on this series. Formula: 7% × contracts × price × (1 − price), rounded up, on orders that take liquidity. Break-even assumes you hold to settlement; trading out early pays the fee twice.

How long until your balance is $0 in this market? →

Open contracts right now

Open contracts in this series with price, implied probability, volume and close time
Contract	YES price	Implied	Fee at this price	Real-world odds	Luck needed	Volume	Closes
When will Beam Therapeutics Inc. submit a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA? · before December	13¢	13%	0.8¢	—	26%	5,052	Dec 01, 15:00 UTC
When will Beam Therapeutics Inc. submit a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA? · before April 2027	79¢	79%	1.2¢	—	42%	3,375	Apr 01, 14:00 UTC
When will Beam Therapeutics Inc. submit a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA? · before 2027	56¢	56%	1.7¢	—	88%	1,733	Jan 01, 15:00 UTC

Who actually wins this market

Whoever posts the resting orders and collects the spread without paying a fee.
The venue, on every fee.
Not, on average, the person clicking buy because the chart is going their way. That was us.

Still want to play? Read the deal first: what the account asks for, what the bonus really is, and whether we are paid. Vendors sell bots for markets like this one; see the bot benchmark before you pay for one.